Latest stock market podcasts

Between the BellsThe Bellcast
Between the Bells

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

Weekly Wrap 3 April

Bell Direct
April 3, 2020

Market Update 2 April

Bell Direct
April 2, 2020

Market Update 1 April

Bell Direct
April 1, 2020

March Market Overview

Bell Direct
March 31, 2020

Market Update 31 March

Bell Direct
March 31, 2020

Weekly Wrap 27 March

Bell Direct
March 27, 2020

Morning Bell 24 March

Bell Direct
March 24, 2020

Morning Bell 23 March

Bell Direct
March 23, 2020

Market Update 20 March

Bell Direct
March 20, 2020

From the Helm: Bubs Australia founder & CEO Kristy Carr, on the global market

Bell Direct
March 19, 2020

Market Update 19 March

Bell Direct
March 19, 2020

Morning Bell 18 March

Bell Direct
March 18, 2020
  1. Pages:
  3. 1
  4. ...
  5. 140
  6. 141
  7. 142
  8. 143
  9. 144
  10. 145
  11. 146
  12. 147